Blood Cancer Journal (Jan 2021)
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma
Abstract
Highlights Primary GI MCL is rare. These patients tend to be treated less aggressively in the frontline setting yet have similar outcomes as those with secondary GI MCL. Less aggressive frontline treatment for primary GI MCL is reasonable given decent outcome, although it is unknown whether more aggressive treatment can result in improved outcomes.